HORIZON EUROPE
Europeo
Scope:Specific challenge: Digital personalised models, tools and standards with application for some specific clinical targets are currently available. There is however a need for greater integration of patient information, for example of multi-scale and multi-level physiological models with current and historical patient specific data and population specific data, to generate new clinical information for patient management. Any such integrative digital representation (Digital Patient) must also allow meaningful knowledge extraction and decision support.
Scope: Proposals should focus on new decision support systems (DSS) based on a complex integration of heterogeneous data sources and subject-specific computer models. This should enable an integrated data analysis, and should present a highly visual data representation, using user-friendly interactive exploratory interfaces in order to assure usability and acceptability.
Proposals should enable the use of DSS by healthcare professionals for personalised prediction and decision in prevention, diagnosis or treatment and should take into account data protection and ethical considerations, as well as those pe...
ver más
Scope:Specific challenge: Digital personalised models, tools and standards with application for some specific clinical targets are currently available. There is however a need for greater integration of patient information, for example of multi-scale and multi-level physiological models with current and historical patient specific data and population specific data, to generate new clinical information for patient management. Any such integrative digital representation (Digital Patient) must also allow meaningful knowledge extraction and decision support.
Scope: Proposals should focus on new decision support systems (DSS) based on a complex integration of heterogeneous data sources and subject-specific computer models. This should enable an integrated data analysis, and should present a highly visual data representation, using user-friendly interactive exploratory interfaces in order to assure usability and acceptability.
Proposals should enable the use of DSS by healthcare professionals for personalised prediction and decision in prevention, diagnosis or treatment and should take into account data protection and ethical considerations, as well as those pertaining to the inherent uncertainties and limits of prediction. The models should be already available, multi-level and multi-scale and will be integrated with the individual and population data relevant for the targeted clinical situations, e.g. the required molecular and cellular data, including genomics and epi-genomics, in vivo and in vitro imaging data, or data on administration of therapeutics and on nutrition/exposure to environmental factors and will be linked when relevant with computer models of personalised physiology, functional disorders and other diseases. The proposed systems should take advantage of the personal medical data accumulated over time. Proposals should include the standardisation of data formats. The integration of data coming from other new technologies for e.g. key-enabling technologies should be considered. Gender and ethical issues should be duly considered.
The Commission considers that proposals requesting a contribution from the EU of between EUR 3 and 5 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
Expected impact:
Better coherent use of health data available for a subject in conjunction with the existing medical knowledge in clinical decision making Design of predictive and therapeutic interventions Better management of complex clinical situations. Enabling use of the same information by different medical services and the other relevant healthcare professionals. Better control and inter-service coordination in the management of the patient health. Providing a consistent view of a patient's care needs. Type of action: Research and innovation actions
Cross-cutting Priorities:Cross-cutting Key-Enabling Technologies (KETs)Gender
ver menos
Características del consorcio
:
La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Características del Proyecto
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Características de la financiación
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding to support its participation in projects supported under all topics in calls under the Societal Challenge ‘Health, demographic change and well-being’.
Evaluation
3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme, with the following exceptions:
The thresholds for each criterion in a single stage process will be 4, 4 and 3.
The cumulative threshold will be 12.
3.2 Guide to the submission and evaluation process
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
Indicative timetable for evaluation and grant agreement:
Information on the outcome of the evaluation: maximum 5 months from the final date for submission.
Signature o... Please read carefully all provisions below before the preparation of your application.
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding to support its participation in projects supported under all topics in calls under the Societal Challenge ‘Health, demographic change and well-being’.
Evaluation
3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme, with the following exceptions:
The thresholds for each criterion in a single stage process will be 4, 4 and 3.
The cumulative threshold will be 12.
3.2 Guide to the submission and evaluation process
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
Indicative timetable for evaluation and grant agreement:
Information on the outcome of the evaluation: maximum 5 months from the final date for submission.
Signature of grant agreements: maximum 3 months from the date of informing successful applicants.
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Research and Innovation Action:
Specific provisions and funding rates
Standard proposal template (administrative forms and structure of technical annex)
Dedicated evaluation form
Annotated Model Grant Agreement
Additional provisions:
Horizon 2020 budget flexibility
Classified information
Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
Frequently Asked Questions (FAQ)
Specific FAQ on this topic
FAQ on all topics of this call
Información adicional de la convocatoria
Otras ventajas
Ayudas Similares
| Abierta
| Próximamente
| Abierta